Highlighting Our Actions for Cardiovascular Care
Amarin in the Media Spotlight
From articles and press releases to social media platforms, learn about Amarin’s initiatives as we drive a new paradigm in preventative cardiovascular care.
Date:
June 24, 2025Format:
Date:
April 28, 2025Format:
Date:
April 7, 2025Format:
Date:
March 31, 2025Format:
Date:
March 19, 2025Format:
Date:
March 12, 2025Format:
Date:
March 12, 2025Format:
1
2
3
4
5
6
7
8
9
10
›
»
Media Contact form
If you’re a journalist or media professional, please feel free to get in touch with our media team by completing the contact form below. If you have a general or product-specific inquiry, go to the contact page ►
MEDIA TOOLKIT
amarin history
A Legacy of Cardiometabolic LEADERSHIP
Find out how Amarin has been creating a new paradigm in cardiovascular disease management for over three decades.
Investor Relations
A BOLD investment in cardiometabolic health
Keeping our investors informed about our progress in helping stop cardiovascular disease from being a leading cause of death is important to us. Click here for our investor presentations, events and financial results.
Science and Health
Passionate about cardiometabolic science and health
Learn more about the science underpinning our product and research & development efforts to advance innovation in cardiovascular disease.
Working at Amarin
A BOLD place for entrepreneurial careers
Are you interested in joining Amarin and being part of our BOLD vision to stop cardiovascular disease from being a leading cause of death worldwide? Click here for more information about our culture, career opportunities, benefits and more.
Disclaimer
The press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Amarin disavows any obligation to update the information contained in such press releases after the date of their issuance.
ALL-NP-00017 1/23
©2025 Amarin Pharmaceuticals Ireland Limited. All rights reserved.
AMARIN, VASCEPA, VAZKEPA and REDUCE-IT names and logos are trademarks of Amarin Pharmaceuticals Ireland Limited. | ALL-NP-00014 1/23
Get In Touch
Whether you’re a patient, a healthcare professional or a job seeker, you can find the best way to contact us from the options below. We’d love to hear from you:
Follow Us
Follow Amarin on our social channels for the latest company news, product campaigns and industry updates:
